2017 Fiscal Year Final Research Report
Netrin-1 as a novel therapeutic target of medulloblastoma
| Project/Area Number |
16K20013
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Neurosurgery
|
|---|
| Research Institution | Hiroshima International University (2017)
Ehime University (2016) |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | 軸索誘導因子 / netrin / 髄芽腫 / 転移 / 血管新生 / 癌幹細胞 |
|---|
| Outline of Final Research Achievements |
Netrin-1, a chemoattractant factor in the neuronal system, promotes tumor progression by enhancing angiogenesis and metastasis. Our recent studies demonstrate that netrin-1 promotes medulloblastoma (MB) cell invasiveness and angiogenesis, therefore, we aim to target netrin-1 signaling for MB therapy.
Netrin-1 acts via several receptors, including UNC5A-D, DCC, DSCAM and neogenin. To identify the key netrin receptor in MB, we purified MB cancer stem like cells and carried out microarray. As a result, one of the netrin receptor was elevated in MB cancer stem cells. We will investigate the function of this receptor in MB and expect this receptor as a novel marker of MB stem cell. We will also screen the inhibitor of this receptor and test with MB model mice.
|
| Free Research Field |
分子細胞生物学
|
